LAS VEGAS, NV--(Marketwired - Feb 11, 2014) - Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) ("Dewmar" or "Company") announced today that in the interest of the Company's major expansion plans into the industrial hemp and medical marijuana industries, the Company has secured a co-branding and professional consulting services agreement with The Industrial Hemp and Medical Marijuana Consulting Company, Inc., a wholly-owned subsidiary of Hemp, Inc. (OTC Pink: HEMP).
"Following an extensive face-to-face meeting in Las Vegas last month with Hemp, Inc. CEO, Bruce Perlowin and his advisors, both teams immediately recognized a natural synergy, and the potential to leverage each other's strengths to take full advantage of this 'once-a-quarter-century' boom that we are soon to experience within the industrial hemp and related industries," said Marco Moran, CEO of Dewmar International BMC, Inc.
Dr. Moran added, "We look forward to continuing to identify beneficial relationships to broaden Dewmar's international consumer footprint with pioneers such as Mr. Perlowin. He was years ahead of everyone in recognizing the many applications of the hemp plant and the enormous economic opportunity. The world is just beginning to catch up with his insight. Bruce Perlowin and Hemp, Inc. are the perfect partners."
According to the signed agreement between the two companies, both companies have created a co-branding partnership whereas they will work together to strategically launch a series of consumable goods that stem from the functional and nutritional components of hemp, which will qualify to be sold in all 50 states.
Bruce Perlowin, CEO of Hemp, Inc. said, "On January 22nd of this year, I had the opportunity to sit down with Dr. Moran at an industry conference. I was quite impressed with his Company and the plans that he has to introduce products infused with hemp into the marketplace over the very short term. We believe that the ultimate economic opportunity that is being created by the new legislation regarding hemp farming is incalculable. Hemp oil, seeds and fiber can be used in many different products and it makes the products better, stronger and greener than the current products on the market. Since Dr. Moran is a licensed pharmacist with extensive relationships within the healthcare community, I believe he will also take advantage of opportunities within healthcare."
Having Hemp, Inc.'s guidance during this great time of growth and expansion for Dewmar International, will allow the company to take advantage of the opportunity existing in the industrial hemp and medical marijuana sector. Dewmar recently reported that it anticipates significant revenue growth for this first quarter of 2014 and has confirmed that it has shed all 'toxic' funders who had placed significant downward pressure on the stock in the previous 12 months. "I believe the public has confidence in the strength and direction of our Company which is creating an influx of business opportunities and potential relationships for Dewmar," said CEO, Dr. Marco Moran. "In addition to positioning the Company for significant and diverse revenue streams for the future, our staff has taken a team approach in reducing our operating costs and total overhead to help improve profitability."
About Dewmar International BMC, Inc.
Dewmar International BMC, Inc. is a leading provider of consumer brands to global markets. The Company's flagship product, LEAN SLOW MOTION POTION™ whose three flavors are Yella, Purp and Easta Pink, is rated as one of the top 3 national selling relaxation beverages currently available in the U.S. market, Trinidad & Tobago, Puerto Rico and Mexico. The Company has entered into significant relationships and business discussions intended to leverage the explosion in national popularity of both the industrial hemp and medical marijuana industry, and forecasts a strong presence in the space for the immediate and long-term future. The company has offices in Clinton, Mississippi; Houston, Texas and Las Vegas, Nevada.
For more information about our Company please visit us at www.DewmarInternational.com. If you are a distributor or retailer inquiring about purchasing our product for resale, please contact us at 1-877-SIP-LEAN or 1-877-747-5326. If you are an Investor please contact us at InvestorRelations@DewmarInternational.com
ABOUT HEMP, INC.
Hemp, Inc. (OTC Pink: HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. (OTC Pink: HEMP) is not involved in the cultivation or marketing of medical marijuana. It is the company's belief that legalization of hemp in all 50 states and at the federal level will come to pass. With that in mind, the company is building infrastructure with the potential to gain substantial market share before and after industrial hemp prohibition ends. (Pending any federal licensing or other requirements, that may be enacted after hemp prohibition ends).
ABOUT THE INDUSTRIAL HEMP AND MEDICAL MARIJUANA CONSULTING COMPANY, INC.
The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of Hemp, Inc. (OTC Pink: HEMP) that pulls industry information from a vast network of specialists that consists of other public industry, public company CEOs, bankers, investors, lawyers, industry analysts, and non-profits connected to the industry. IHMMCC is entrenched in all the multi-faceted opportunities in the medical marijuana and Industrial Hemp industry. (www.HempInc.com)
Safe Harbor Statement
This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, general economic conditions and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.